Advancing Laboratory Safety: A Strategic Analysis of the Global PET Blood Collection Tube Industry,
公開 2026/03/27 15:28
最終更新
-
Global Leading Market Research Publisher QYResearch announces the release of its latest report “PET Non-vacuum Blood Collection Tube - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global PET Non-vacuum Blood Collection Tube market, including market size, share, demand, industry development status, and forecasts for the next few years.
For hospitals, diagnostic laboratories, and blood collection centers, the reliability and safety of blood collection consumables directly impact specimen integrity, patient safety, and diagnostic accuracy. Traditional glass collection tubes, while effective, present risks of breakage, require careful handling, and contribute to laboratory waste. PET non-vacuum blood collection tubes address these challenges with consumables manufactured primarily from polyethylene terephthalate (PET), offering advantages including high transparency, good mechanical strength, and strong rupture resistance. These tubes are widely used in clinical practice for collecting and preserving blood samples across hospitals, testing centers, and blood centers, providing a safer, more durable alternative to glass while maintaining specimen integrity. The global market for PET non-vacuum blood collection tubes was valued at US$ 1,541 million in 2025 and is projected to grow at a CAGR of 7.0% to reach US$ 2,455 million by 2032, driven by increasing clinical testing volumes, the expansion of healthcare infrastructure in emerging markets, and the ongoing transition from glass to plastic consumables in diagnostic settings. In 2024, global sales reached approximately 12 billion units, with an average selling price of US$ 0.12 per unit.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6098323/pet-non-vacuum-blood-collection-tube
Market Definition and Product Segmentation
PET non-vacuum blood collection tubes represent a specialized category within the medical consumables market, distinguished by their material composition (PET plastic) and non-vacuum design. Unlike vacuum tubes that contain pre-measured negative pressure for automatic filling, non-vacuum tubes require manual filling, offering flexibility for specific collection protocols and applications where precise volume control is required.
Capacity Segmentation
The market is stratified by tube volume, each addressing distinct clinical applications:
Capacity 2-4 mL: The dominant segment for routine hematology and chemistry testing, suitable for standard blood draws in hospital and laboratory settings.
Capacity 10-15 mL: Serving applications requiring larger sample volumes, including specialized testing, research protocols, and blood banking.
Capacity 30-50 mL: The niche segment for high-volume applications, including autologous blood collection, research, and specialized clinical protocols.
Application Segmentation
The market serves critical healthcare sectors:
Hospital: The largest segment, encompassing inpatient and outpatient collection, emergency departments, and clinical laboratories within hospital systems.
Testing Agency: Serving independent clinical laboratories, reference labs, and diagnostic service providers including third-party testing organizations.
Others: Including blood centers, research institutions, and public health facilities.
Industry Value Chain and Competitive Landscape
Upstream Supply Chain
The PET blood collection tube industry relies on specialized upstream suppliers:
PET Resin Suppliers: Major suppliers including SABIC, Mitsubishi Chemical, DuPont, and Lanxess provide the high-quality PET resin essential for tube manufacturing.
Additives and Rubber Stoppers: Manufacturers of stoppers, additives, and sterilization-compatible components ensure product safety and functionality.
Downstream Customers
End-user segments include:
Hospitals: Mayo Clinic, Union Hospital, and healthcare systems globally
Third-Party Testing Organizations: Dian Diagnostics, LabCorp, Quest Diagnostics, and independent clinical laboratories
Public Health Blood Collection Centers: Government and non-profit blood collection facilities
Competitive Landscape
The market features a competitive landscape combining specialized medical consumables manufacturers with regional players. Key players include KS Medical, BOENMED, Siny Medical, Chongqing New World Trading Company, Chengdu PUTH Medical Plastics Packaging Co., Ltd., Krupa Labequi, Rollmed, Henso Medical, Nasmed Diagnostics Pvt. Ltd., FUKANG, and Berpu Medical.
Industry Development Characteristics
1. Glass-to-Plastic Transition
A case study from QYResearch's industry monitoring reveals that healthcare facilities globally are transitioning from glass to plastic blood collection tubes. PET tubes offer reduced breakage risk, lower shipping weight, and elimination of sharps hazards associated with broken glass, improving laboratory safety and reducing waste disposal costs.
2. Healthcare Infrastructure Expansion
The expansion of healthcare infrastructure in emerging markets—including China, India, Southeast Asia, and Latin America—has driven demand for diagnostic consumables. A case study from the healthcare sector indicates that new hospital construction, laboratory network expansion, and universal health coverage initiatives increase the installed base of facilities requiring reliable collection supplies.
3. Clinical Testing Volume Growth
Increasing prevalence of chronic diseases, aging populations, and expanded diagnostic testing have driven growth in clinical testing volumes. A case study from the diagnostic industry indicates that global testing volumes have grown steadily, creating sustained demand for collection consumables.
4. Sterility Assurance and Biosafety
Advancements in sterility assurance technologies and biosafety requirements have elevated product specifications. A case study from the medical device sector indicates that manufacturers investing in radiation sterilization, validated sterile barriers, and contamination-free manufacturing capture preference in healthcare procurement.
Exclusive Industry Insights: The Sustainability Frontier
Our proprietary analysis identifies sustainability as an emerging competitive frontier in the PET blood collection tube market. With healthcare institutions increasingly prioritizing environmental impact reduction, manufacturers developing biodegradable alternatives, recyclable materials, and reduced plastic consumption formulations capture differentiation. The future development of the market will focus on automated production, upgraded sterility assurance technologies, enhanced biosafety performance, and the use of biodegradable alternative materials to meet the growing demands of the global clinical testing market and promote the development of green healthcare.
Strategic Outlook
For industry executives, investors, and marketing leaders evaluating opportunities in the PET non-vacuum blood collection tube market, the projected 7.0% CAGR reflects sustained demand from healthcare infrastructure expansion, clinical testing growth, and the ongoing glass-to-plastic transition. Manufacturers positioned to capture disproportionate share share three characteristics: demonstrated expertise in medical-grade PET processing and sterile manufacturing; product portfolios spanning multiple capacity ranges; and established relationships with hospital systems, laboratory networks, and medical distributors. As the market evolves toward automation-ready designs, enhanced biosafety features, and sustainable materials, the ability to deliver reliable, high-quality collection tubes will define competitive leadership.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
For hospitals, diagnostic laboratories, and blood collection centers, the reliability and safety of blood collection consumables directly impact specimen integrity, patient safety, and diagnostic accuracy. Traditional glass collection tubes, while effective, present risks of breakage, require careful handling, and contribute to laboratory waste. PET non-vacuum blood collection tubes address these challenges with consumables manufactured primarily from polyethylene terephthalate (PET), offering advantages including high transparency, good mechanical strength, and strong rupture resistance. These tubes are widely used in clinical practice for collecting and preserving blood samples across hospitals, testing centers, and blood centers, providing a safer, more durable alternative to glass while maintaining specimen integrity. The global market for PET non-vacuum blood collection tubes was valued at US$ 1,541 million in 2025 and is projected to grow at a CAGR of 7.0% to reach US$ 2,455 million by 2032, driven by increasing clinical testing volumes, the expansion of healthcare infrastructure in emerging markets, and the ongoing transition from glass to plastic consumables in diagnostic settings. In 2024, global sales reached approximately 12 billion units, with an average selling price of US$ 0.12 per unit.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6098323/pet-non-vacuum-blood-collection-tube
Market Definition and Product Segmentation
PET non-vacuum blood collection tubes represent a specialized category within the medical consumables market, distinguished by their material composition (PET plastic) and non-vacuum design. Unlike vacuum tubes that contain pre-measured negative pressure for automatic filling, non-vacuum tubes require manual filling, offering flexibility for specific collection protocols and applications where precise volume control is required.
Capacity Segmentation
The market is stratified by tube volume, each addressing distinct clinical applications:
Capacity 2-4 mL: The dominant segment for routine hematology and chemistry testing, suitable for standard blood draws in hospital and laboratory settings.
Capacity 10-15 mL: Serving applications requiring larger sample volumes, including specialized testing, research protocols, and blood banking.
Capacity 30-50 mL: The niche segment for high-volume applications, including autologous blood collection, research, and specialized clinical protocols.
Application Segmentation
The market serves critical healthcare sectors:
Hospital: The largest segment, encompassing inpatient and outpatient collection, emergency departments, and clinical laboratories within hospital systems.
Testing Agency: Serving independent clinical laboratories, reference labs, and diagnostic service providers including third-party testing organizations.
Others: Including blood centers, research institutions, and public health facilities.
Industry Value Chain and Competitive Landscape
Upstream Supply Chain
The PET blood collection tube industry relies on specialized upstream suppliers:
PET Resin Suppliers: Major suppliers including SABIC, Mitsubishi Chemical, DuPont, and Lanxess provide the high-quality PET resin essential for tube manufacturing.
Additives and Rubber Stoppers: Manufacturers of stoppers, additives, and sterilization-compatible components ensure product safety and functionality.
Downstream Customers
End-user segments include:
Hospitals: Mayo Clinic, Union Hospital, and healthcare systems globally
Third-Party Testing Organizations: Dian Diagnostics, LabCorp, Quest Diagnostics, and independent clinical laboratories
Public Health Blood Collection Centers: Government and non-profit blood collection facilities
Competitive Landscape
The market features a competitive landscape combining specialized medical consumables manufacturers with regional players. Key players include KS Medical, BOENMED, Siny Medical, Chongqing New World Trading Company, Chengdu PUTH Medical Plastics Packaging Co., Ltd., Krupa Labequi, Rollmed, Henso Medical, Nasmed Diagnostics Pvt. Ltd., FUKANG, and Berpu Medical.
Industry Development Characteristics
1. Glass-to-Plastic Transition
A case study from QYResearch's industry monitoring reveals that healthcare facilities globally are transitioning from glass to plastic blood collection tubes. PET tubes offer reduced breakage risk, lower shipping weight, and elimination of sharps hazards associated with broken glass, improving laboratory safety and reducing waste disposal costs.
2. Healthcare Infrastructure Expansion
The expansion of healthcare infrastructure in emerging markets—including China, India, Southeast Asia, and Latin America—has driven demand for diagnostic consumables. A case study from the healthcare sector indicates that new hospital construction, laboratory network expansion, and universal health coverage initiatives increase the installed base of facilities requiring reliable collection supplies.
3. Clinical Testing Volume Growth
Increasing prevalence of chronic diseases, aging populations, and expanded diagnostic testing have driven growth in clinical testing volumes. A case study from the diagnostic industry indicates that global testing volumes have grown steadily, creating sustained demand for collection consumables.
4. Sterility Assurance and Biosafety
Advancements in sterility assurance technologies and biosafety requirements have elevated product specifications. A case study from the medical device sector indicates that manufacturers investing in radiation sterilization, validated sterile barriers, and contamination-free manufacturing capture preference in healthcare procurement.
Exclusive Industry Insights: The Sustainability Frontier
Our proprietary analysis identifies sustainability as an emerging competitive frontier in the PET blood collection tube market. With healthcare institutions increasingly prioritizing environmental impact reduction, manufacturers developing biodegradable alternatives, recyclable materials, and reduced plastic consumption formulations capture differentiation. The future development of the market will focus on automated production, upgraded sterility assurance technologies, enhanced biosafety performance, and the use of biodegradable alternative materials to meet the growing demands of the global clinical testing market and promote the development of green healthcare.
Strategic Outlook
For industry executives, investors, and marketing leaders evaluating opportunities in the PET non-vacuum blood collection tube market, the projected 7.0% CAGR reflects sustained demand from healthcare infrastructure expansion, clinical testing growth, and the ongoing glass-to-plastic transition. Manufacturers positioned to capture disproportionate share share three characteristics: demonstrated expertise in medical-grade PET processing and sterile manufacturing; product portfolios spanning multiple capacity ranges; and established relationships with hospital systems, laboratory networks, and medical distributors. As the market evolves toward automation-ready designs, enhanced biosafety features, and sustainable materials, the ability to deliver reliable, high-quality collection tubes will define competitive leadership.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
About Us：
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedi…
最近の記事
タグ